Switch Therapeutics Inc. has announced its first development candidate, a liver-sparing APOE (apolipoprotein E) RNAi therapy for treatment of Alzheimer’s disease in APOE4 carriers. Switch’s ...
Sickle cell disease affects 100,000 in the U.S., especially the Black community. On “The WAOK Morning Show,” Glinda Dames-Fincher discussed how race and socioeconomics impact care.
In 2021, alcohol-related liver cirrhosis accounted for about a quarter of the 46·4 million disability-adjusted life-years (DALYs) lost from liver disease globally, making alcohol a leading cause of ...
SEQUANA MEDICAL ANNOUNCES UPDATE ON SECOND TRANCHE OF CONVERTIBLE BRIDGE LOAN Ghent, Belgium – 2 December 2024 – (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the ...